Oryzon Genomics S.A. (BME:ORY)

Oryzon Genomics Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	5.62	12.26	21.32	28.72	39.6
Cash & Short-Term Investments	5.62	12.26	21.32	28.72	39.6
Cash Growth	-54.16%	-42.50%	-25.79%	-27.47%	12.35%
Other Receivables	3.13	2.01	3.84	3.78	2.46
Receivables	3.13	2.01	3.84	3.78	2.46
Inventory	0	0.01	0.01	0.1	0.32
Other Current Assets	-	0	-	-	0
Total Current Assets	8.75	14.28	25.16	32.61	42.38
Property, Plant & Equipment	0.36	0.48	0.61	0.68	0.64
Long-Term Investments	-	-	-	-	0.04
Other Intangible Assets	97.1	0.38	0.52	0.63	0.21
Long-Term Deferred Tax Assets	2.39	2.22	2.05	1.81	1.8
Long-Term Deferred Charges	-	89.51	75.32	59.62	49.01
Other Long-Term Assets	0.13	0.03	0.03	0.03	0.03
Total Assets	108.72	106.9	103.7	95.38	94.11
Accounts Payable	2.13	3.41	5.06	2.91	2
Accrued Expenses	0.8	0.6	0.54	1.24	0.62
Short-Term Debt	8.74	-	-	-	0.14
Current Portion of Long-Term Debt	-	11.92	12.17	4.17	4.71
Current Portion of Leases	0.02	0.02	0.02	-	-
Other Current Liabilities	0.05	0.46	0.93	0.35	0.22
Total Current Liabilities	11.74	16.41	18.73	8.67	7.69
Long-Term Debt	7.42	6.28	10.27	13.35	8.68
Long-Term Leases	0.03	0.06	0.08	-	-
Long-Term Deferred Tax Liabilities	2.39	2.22	2.05	1.81	1.8
Other Long-Term Liabilities	-	0.15	-	-	-
Total Liabilities	21.67	25.13	31.13	24.12	18.18
Common Stock	3.29	3.06	2.78	2.65	2.65
Additional Paid-In Capital	100.71	92.38	79.69	73.96	73.96
Retained Earnings	-19.29	-15.62	-12.27	-8.04	-3.35
Treasury Stock	-2.03	-0.55	-0.62	-0.69	-0.69
Comprehensive Income & Other	4.36	2.51	3	3.38	3.36
Shareholders' Equity	87.04	81.77	72.57	71.26	75.93
Total Liabilities & Equity	108.72	106.9	103.7	95.38	94.11
Total Debt	16.21	18.27	22.54	17.52	13.53
Net Cash (Debt)	-10.59	-6.02	-1.22	11.2	26.07
Net Cash Growth	-	-	-	-57.02%	18.46%
Net Cash Per Share	-0.16	-0.10	-0.02	0.21	0.49
Filing Date Shares Outstanding	64.37	60.88	55.29	52.76	52.76
Total Common Shares Outstanding	64.37	60.88	55.29	52.76	52.76
Working Capital	-2.99	-2.14	6.43	23.93	34.68
Book Value Per Share	1.35	1.34	1.31	1.35	1.44
Tangible Book Value	-10.05	81.39	72.05	70.63	75.72
Tangible Book Value Per Share	-0.16	1.34	1.30	1.34	1.44
Machinery	-	1.62	1.64	1.6	1.56

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.